Inovio's DNA vaccine trial on hold over delivery device shelf life concerns
The US FDA has placed a Phase III trial of Inovio’s candidate DNA cancer vaccine VGX-3100 on clinical hold over concerns about its delivery device.
Archives for October 24, 2016
Aduro told to halt cancer vaccine trial enrollment after listeria found in patient sample
The US FDA has told Aduro Biotech not to enrol subjects in trials of its listeria-based immunotherapies after one study subject tested positive for the bacteria.